A new study shows lipid nanoparticles can be formulated at much higher lipid concentrations using a modular mixing approach, ...
Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...
Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.
The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...
The team applied this method to mRNA/saRNA constructs from 1 to 10 kb and assessed pH ranges from 3 to 6. For all the RNA constructs, the J2 immunoblot signal—a marker for dsRNA strands—decreased with ...
Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics for RNA therapeutics, today announced the acquisition of Terrain Bio, a techbio company specializing in AI/ML RNA ...
While a majority of the therapies currently in development are life-long treatments, Genespire is taking a different approach ...
Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...
Key market opportunities in the RNA Therapy Clinical Trials sector include an increase in chronic and rare diseases, advancements in delivery technologies like lipid nanoparticles, robust venture ...
COVID-19 vaccine stock Moderna just got its biggest lift in recent memory, moving up 17%. Can MRNA stage a broader recovery, ...
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
The transaction process began with a successful tender offer concluded by BioNTech on December 18, 2025, through which it secured approximately 86.75% of CureVac's outstanding shares. Subsequently, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results